INTRODUCTION
Skeletal muscle has a high, but not inexhaustible, capacity to regenerate following injury. In chronic myopathies, such as Duchenne muscular dystrophy (DMD), fat and fibrotic scar gradually replace functional muscle, a process termed fatty degeneration (Serrano et al., 2011) . Replacement of muscle by adipocytes also characterizes age-related sarcopenia and certain chronic diseases, including type 2 diabetes (Mitchell et al., 2012) . How intercellular communication coordinates muscle regeneration, and how these interactions go awry to cause fatty degeneration in disease and aging, is unclear.
In addition to myogenic stem cells (MuSCs), also called satellite cells, muscle contains a second progenitor population, the non-myogenic mesenchymal cells called fibro/adipogenic progenitors (FAPs) (Joe et al., 2010; Uezumi et al., 2010) . Injury induces FAPs to proliferate and promote MuSCs to form muscle (Joe et al., 2010; Uezumi et al., 2010) . However, in chronic diseases, FAPs are thought to produce excess extracellular matrix (ECM) components and adipocytes, contributing to fatty degeneration (Joe et al., 2010; Lemos et al., 2015; Uezumi et al., 2011) .
Many vertebrate cells possess a primary cilium, a single immotile cilium that functions in intercellular communication. During vertebrate development, primary cilia are essential for transducing Hh signals and communicating both the on and off states to the nucleus (Goetz and Anderson, 2010) . In the absence of Hh signals, the cilium processes GLI transcription factors into an off state to maintain repression of Hh target genes (Hui and Angers, 2011) . Upon binding of a Hh ligand (e.g., Sonic hedgehog [SHH] , Indian hedgehog [IHH] or Desert hedgehog [DHH] ) to the receptor, PTCH1, Smoothened (SMO) accumulates in the cilium to activate GLI transcription factors. Loss of cilia blocks both the formation of GLI repressor and activator, causing Hh-insensitive, low-level misexpression of Hh target genes (Liu et al., 2005; May et al., 2005) .
During skeletal muscle development, Hh signaling helps to initiate the myogenic program (Hu et al., 2012) . Upon muscle injury, Shh expression increases and may suppress fibrosis and inflammation (Straface et al., 2009) . In aged mice and in a mouse model of DMD, forced expression of Shh increases MuSC proliferation, further suggesting that activating the Hh pathway in muscle may have therapeutic benefits (Piccioni et al., 2014a; Piccioni et al., 2014b) .
We investigated how ciliary signaling functions in muscle regeneration. We found that the majority of ciliated cells within the muscle are FAPs, which dramatically, but transiently, increase ciliation during muscle regeneration. Genetically removing cilia from FAPs protected muscle from adipogenesis following injury or upon mutation of mouse Dystrophin (Dmd), the gene mutated in DMD. Preventing FAP ciliation also enhanced myogenesis after acute injury and inhibited the loss of large muscle fibers in DMD mice. Removing cilia blocked the formation of the transcriptional repressor form of GLI3, thereby de-repressing Hh target genes. Preventing the formation of GLI3 repressor by removing PTCH1 function in FAPs or activating SMO via a small-molecule agonist also blocked adipogenesis, indicating that ciliary Hh signaling controls conversion of FAPs into adipocytes. We found that ciliary signaling regulates the induction of a novel Hh downstream target, TIMP3, a secreted metalloproteinase inhibitor. TIMP3 potently inhibited adipogenesis, and treating mice with a pharmacological inhibitor of metalloproteinases prevented injury-induced adipogenesis. Thus, our results reveal that FAPs utilize ciliary Hh signaling to coordinate the regenerative response to skeletal muscle injury.
RESULTS

FAPs Are Dynamically Ciliated during Muscle Regeneration
As vertebrates require cilia to interpret Hh signals, we hypothesized that ciliated cells would be involved in responding to Hh signals following injury. Therefore, we investigated which cell types are ciliated during muscle regeneration. Primary cilia were identified by staining for acetylated tubulin (TUB AC ) or the ciliary membrane marker ARL13B, and basal bodies were identified by staining for NINEIN or g-TUBULIN ( Figure S1A ). We stained the mouse tibialis anterior muscle for ARL13B and confirmed that myofibers were not ciliated (Przybylski, 1971) ( Figure S1B ). MuSCs, identified by PAX7 expression, were rarely ciliated ( Figure S1C ). In contrast, FAPs, expressing PDGFRa, were frequently ciliated and accounted for the majority of ciliated cells within skeletal muscle ( Figure 1A and Figure S1D ). To determine whether the ciliation of FAPs changes during regeneration, we utilized two distinct muscle injury models with similar regeneration kinetics. Intramuscular injection of either cardiotoxin or glycerol causes transient necrosis of muscle fibers, with cardiotoxin inducing little adipogenesis and glycerol inducing more (Pisani et al., 2010) . We injected cardiotoxin or glycerol into tibialis anterior muscles of 10-to 12-week-old wild-type (WT) mice and analyzed the number and ciliation of FAPs at different time points post injury. As previously described (Lemos et al., 2015) , muscle injury transiently increased the number of FAPs ( Figures 1A and 1B) . Intriguingly, the proportion of FAPs with cilia also increased sharply, regardless of injury type, from 10% to almost 50% before returning to pre-injury levels at 21 days post injury (dpi) (Figures 1A and 1C) . Thus, a portion of FAPs are ciliated prior to an injury, and FAP ciliation sharply increases during muscle repair, raising the possibility that FAPs and cilia participate in regeneration.
FAP Cilia Control Injury-Induced Adipogenesis
As PDGFRa is uniquely expressed by FAPs within the muscle ( Figures 1A and 2A ), we used a tamoxifen-inducible PdgfraCreERT allele to genetically manipulate FAPs in vivo. To validate the specificity of recombination, we generated Pdgfra-CreERT Rosa26 EYFP mice, which express EYFP in PDGFRa-expressing cells and their progeny upon administration of tamoxifen (Figure 2A) . Both before injury and 7 dpi with cardiotoxin injection, the majority of FAPs of tamoxifen-treated Pdgfra-CreERT Rosa26 EYFP mice expressed EYFP ( Figure 2A ). Lineage tracing of FAPs using Pdgfra-CreERT Rosa26 EYFP mice demonstrated that the majority of PERILIPIN-expressing adipocytes induced after injury with glycerol also expressed EYFP (Figure 2A ), indicating that FAPs are the major source of injury-induced adipocytes in skeletal muscle.
To assess whether FAP cilia function in muscle regeneration, we conditionally deleted Ift88, a gene required for ciliogenesis and ciliary maintenance, in FAPs of adult mice using PdgfraCreERT. Tamoxifen treatment recombined Ift88 and caused a near complete loss of FAP cilia ( Figure S2A ). Pdgfra-CreERT Ift88 c/À mice to which we administered tamoxifen are referred to hereafter as FAP no cilia mice. Tamoxifen-treated littermates of FAP no cilia mice that either lacked the Pdgfra-CreERT or possessed a WT Ift88 allele served as controls ( Figure S2B ). qRT-PCR analysis revealed that expression of Ift88 did not recover in FAP no cilia muscle over the period we observed muscle regeneration ( Figure S2C ).
We used FAP no cilia mice to assess the function of FAP cilia.
Loss of FAP cilia had a strong impact on adipogenesis (Figure 2B) . Following glycerol-induced injury, control mice, regardless of sex, exhibited extensive infiltration of PERILIPIN-and Fatty acid binding protein 4 (FABP4)-expressing adipocytes throughout the muscle ( Figures 2B and S2B ). In comparison, FAP no cilia mice displayed > 70% reduction in the number of adipocytes, both 7 and 21 dpi ( Figures 2B and 2C ). The adipocytes in FAP no cilia mice were of comparable size to those of control mice, suggesting that loss of FAP cilia affected adipogenesis, but not maturation ( Figure S2D ). Although cardiotoxin induced fewer adipocytes in control mice, FAP no cilia mice injured with cardiotoxin also displayed decreased adipogenesis 21 dpi ( Figure S2E ). We confirmed the difference in adipogenesis by comparing the expression levels of mature adipocyte markers such as Adiponectin (Adipoq) and Fapb4 in whole-muscle RNA lysates in an independent cohort of mice. Glycerol injury induced Adipoq and Fabp4 expression in control, but not in FAP no cilia mice (Figure 2D) . Thus, FAP cilia control adipogenesis following muscle injury.
FAP Cilia Regulate Intramuscular Adipogenesis in a
Model of DMD DMD is a severe human myopathy in which mutations in the DMD gene encoding DYSTROPHIN cause progressive myofiber death, fibrosis, and replacement of myofibers with adipocytes (Hoffman et al., 1987 athy associated with intramuscular adipogenesis (Bulfield et al., 1984 (Figure 3C-3E ). To understand whether loss of FAP cilia decreased degeneration or increased regeneration, we analyzed the frequency of myofibers with centrally located nuclei, a proxy for regenerating fibers (McDonald et al., 2015) . Compared to Dmd mdx mice, Dmd mdx FAP no cilia mice displayed increased proportions of myofibers with centrally located nuclei, suggestive of enhanced myofiber repair ( Figure S3D ). Thus, in addition to reducing adipogenesis, removal of FAP cilia in Dmd mdx mice was associated with increased myofiber size.
To determine whether the effect of loss of FAP cilia also affects muscle regeneration after acute injury, we analyzed myofiber size 21 days after glycerol injury. Compared to control mice, FAP no cilia mice exhibited an increased myofiber cross-sectional area following injury ( Figure S3E ). To test whether the increased fiber size following injury in FAP no cilia mice was associated with changes in muscle regeneration, we assessed the expression of embryonic myosin (embryonic myosin heavy chain 3, MYH3) 5 and 7 days post glycerol injury. Transient re-expression of MYH3 is a hallmark of newly formed myofibers (d 'Albis et al., 1988) . FAP no cilia mice produced more than 3-fold more MYH3-expressing myofibers than control mice 5 dpi ( Figure S3F ). In control mice, the prevalence of MYH3-expressing myofibers increased from 5 days to 7 days post glycerol injury ( Figure S3F ). In contrast, in FAP no cilia mice, more MYH3-expressing myofibers are present at 5 than 7 dpi ( Figure S3F ). Thus, FAP cilia affect myofiber size and the extent and timing of MYH3 expression following injury, suggesting that cilia act within FAPs to restrain regeneration of myofibers.
Cilia Repress FAP Expression of Hh Target Genes
In vertebrates, primary cilia participate in Hh signal transduction by both activating GLI transcription factors and generating the GLI transcriptional repressors that repress Hh target genes in the absence of Hh signals (Hui and Angers, 2011) . To assess whether primary cilia control the expression of Hh target genes in FAPs, we evaluated the expression of the Hh target genes, Gli1 and Ptch1. qRT-PCR analysis of whole muscle 5 dpi with glycerol injection revealed that removing IFT88 from FAPs increased Gli1 and Ptch1 expression ( Figure 4A ). To test which cells induced Ptch1, we examined the activity of Ptch1-lacZ, a reporter of Hh signaling (Goodrich et al., 1997) . Both before and 5 days after glycerol injury, we detected no Ptch1-lacZ activity in myofibers ( Figure S4A ). To assess whether the detected increase in Hh target gene expression occurred in FAPs, we purified control FAPs and FAPs lacking IFT88 from regenerating muscle using magneticactivated cell sorting (MACS). 3 dpi with glycerol injection, we isolated FAPs from dissociated tibialis anterior muscle using and FAP no PTCH1 (n = 7) mice 7 dpi.
(E) Immunofluorescence of adipocytes (PERILIPIN, green) of WT mice tibialis anterior muscle 7 dpi with injection of glycerol and either DMSO or SAG at day 0, 2, and 4. Scale bar, 500 mm. Right: quantifications of the number of adipocytes per mm 2 of injured area 7 dpi (n = 5-9 per treatment group). (F-H) qRT-PCR analysis of RNA isolated from whole tibialis anterior muscle without injury or 3 and 5 dpi with injection of cardiotoxin (gray) or glycerol (orange) (n = 4 per time point and injury) for ( combined negative and positive MACS. The purified FAPs were highly enriched for PDGFRa expression, a FAP marker ( Figure S4B ). As with whole muscle, qRT-PCR analysis revealed that removal of IFT88 in FAPs 3 dpi with glycerol increased Gli1 and Ptch1 expression ( Figure 4B ). Thus, removing cilia from FAPs increases the expression of Hh target genes. In the developing limb bud, primary cilia inhibit Gli1 and Ptch1 expression by promoting GLI3 repressor formation (Liu et al., 2005; May et al., 2005) . To test whether cilia function similarly in FAPs, we assessed GLI3 repressor formation in purified FAPs 3 dpi with glycerol injection. We found that IFT88 is required for FAPs to process GLI3 into the repressor, consistent with the possibility that the elevated expression of Hh target genes in FAPs lacking cilia is due to de-repression secondary to loss of GLI3 repressor ( Figure 4C ).
We hypothesized that the upregulation of Hh target gene expression caused by loss of cilia inhibited adipogenesis. To test this hypothesis, we assessed whether activating Hh signal transduction in FAPs was sufficient to block injury-induced adipogenesis. PTCH1 represses the Hh pathway, and deletion of Ptch1 causes constitutive Hh pathway activation (Goodrich et al., 1997) . Therefore, we generated Pdgfra-CreERT Ptch1 c/c mice (referred hereafter to as FAP no PTCH1 mice) to, upon tamoxifen administration, remove Ptch1 and activate the Hh pathway specifically in FAPs. Littermates lacking either Pdgfra-CreERT or possessing a WT allele of Ptch1 served as controls ( Figure S4C ). qRT-PCR 5 dpi with glycerol injection indicated that deletion of Ptch1 in FAPs induced Gli1 expression ( Figure S4D ). FAP no PTCH1 mice displayed an almost complete block in the generation of adipocytes 7 dpi with glycerol injection (Figures 4D and S4C) . As an independent assessment, we compared the expression levels of the adipocyte markers Adipoq and Perilipin in control and FAP no PTCH1 mice 5 dpi with glycerol injection. Injury did not induce these adipocyte markers specifically in FAP no PTCH1 mice ( Figure S4E ).
As an alternative means of activating Hh signaling, we injected a small-molecule Smoothened agonist (SAG) 0, 2, and 4 dpi with glycerol (Chen et al., 2002) . SAG reduced adipogenesis by half at 7 dpi relative to DMSO vehicle control ( Figure 4E ). Thus, activating Hh signaling in FAPs, like removing cilia, strongly inhibits injury-induced intramuscular adipogenesis, suggesting that FAP cilia promote adipogenesis by restraining Hh target gene expression.
Glycerol injection produces a more potent adipogenic injury than does cardiotoxin injection. Consistent with this observation, qRT-PCR analysis of the expression of the adipocyte master regulator, Peroxisome proliferator-activated receptor g (Pparg) in whole tibialis anterior muscle revealed that, whereas both injuries induce Pparg, only glycerol injection caused sustained induction of Pparg ( Figure 4F ).
Given that Hh signaling represses injury-associated adipogenesis, we hypothesized that cardiotoxin, which is weakly adipogenic, activates Hh signaling more than glycerol. Assessing Gli1 and Ptch1 expression by qRT-PCR indicated that cardiotoxin injection induces Hh signaling at 3 and 5 dpi, but glycerol injection does not ( Figure 4G ). To examine whether cardiotoxin activates Hh signaling through an Hh ligand, we investigated its ability to induce Shh, Ihh, or Dhh. qRT-PCR analysis indicated that cardiotoxin, but not glycerol, induced the expression of Dhh ( Figure 4H ). Immunofluorescent staining revealed that Schwann cells within the muscle express DHH ( Figure 4I ), as previously reported (Renault et al., 2013) . Thus, injury with cardiotoxin, but not glycerol, induces DHH expression, activating Hh signaling.
Cilia Promote FAP Differentiation into Adipocytes
As Hh signaling can promote proliferation, inhibit cell death, or direct differentiation, we tested the possibility that cilia inhibit adipogenesis through effects on FAP proliferation, cell death, or differentiation. To determine whether cilia affect the proliferation of FAPs following injury, we injured FAP no cilia mice and quantified PDGFRa-expressing FAPs. During the initial 5 dpi, removing IFT88 from FAPs did not affect the number of intramuscular FAPs ( Figure S5A ). To further assess whether cilia affect FAP proliferation, we administered BrdU to FAP no cilia and control mice either 2 hr prior to tissue harvesting at the indicated time points post injury ( Figure S5B ) or repeatedly over the first two days post injury ( Figure S5C ). Loss of IFT88 caused no significant difference in the proliferation index of FAPs, further supporting the conclusion that cilia do not restrain adipogenesis through effects on FAP expansion (Figures S5B and S5C) . To determine whether FAP cilia inhibit apoptosis, we measured the proportion of FAPs positive for cleaved CASPASE3, a marker of apoptosis, in control and FAP no cilia mice ( Figure S5D ). Removal of IFT88 did not affect apoptosis, indicating that alterations in cell survival also do not account for cilium-dependent effects on adipogenesis.
To test the idea that FAP cilia regulate adipocyte differentiation, we examined the induction of transcription factors of the CCAAT/enhancer-binding protein family (C/EBPa and C/EBPb) and PPARg, regulators of early adipocyte differentiation. We used MACS to isolate FAPs from control and FAP no cilia muscle 3 dpi with glycerol injection, a time before mature adipocytes have formed. qRT-PCR analysis of these FAPs demonstrated that IFT88 is required for the full induction of C/ebpa, C/ebpb, and Pparg, suggesting that cilia are critical for an early step in adipocyte differentiation ( Figure 5A ).
FAP Cilia Restrict Adipogenesis through a Non-cellautonomous Mechanism
In neural and limb-bud patterning, ciliary Hh signaling is thought to act cell autonomously to direct differentiation. To address whether cilia affect FAP differentiation cell autonomously, we generated Pdgfra-CreERT Ift88 c/À Rosa26 EYFP mice (referred to here as FAP lineage + no cilia ) to remove IFT88 and indelibly mark
FAPs and their descendants with EYFP ( Figure 5B ). EYFP-expressing FAPs of FAP lineage + no cilia mice exhibited an 85% reduction in ciliation ( Figures S5E and S5F ). Removing cilia did not affect the number of EYFP-expressing FAPs after injury, further indicating that FAP cilia do not affect proliferation or cell death ( Figure S5G ). To assess whether cilia affect adipogenesis cell autonomously or non-autonomously, we induced recombination in a subset of FAPs ( Figure 5B ). If cilia restrict adipogenesis cell autonomously, we reasoned that EYFP-marked FAPs without cilia should give rise to fewer adipocytes than do EYFP-negative FAPs that retain cilia. If FAP cilia act non-cell-autonomously, the number of both EYFP-positive and EYFP-negative adipocytes should be reduced following deletion of cilia in the EYFPmarked FAPs.
Following a moderate dose of tamoxifen, approximately 60% of adipocytes in control mice expressed EYFP at 21 dpi (Figure 5C and D) . The proportion of adipocytes expressing EYFP in FAP lineage + no cilia mice was the same as that of FAP lineage mice at both 5 and 21 dpi ( Figure 5C and D Figures S5H and S5I) . Therefore, the cilia of FAPs promote adipogenesis non-cell-autonomously in both acute injury and chronic degeneration. As non-cell-autonomous effects are often mediated via secreted signals, we investigated whether ciliary Hh signaling controlled the production of a secreted inhibitor of adipogenesis.
Ciliary Hedgehog Signaling Induces TIMP3, an Inhibitor of Adipocyte Formation Soon after injury (3 dpi), FAP no cilia mice showed reduced induction of the early adipocyte regulators C/ebpa, C/ebpb, and Pparg ( Figure S5A ). To more fully understand the ciliumdependent regulation of injury-induced adipogenesis, we used RNA sequencing (RNA-seq) to transcriptionally profile FAPs purified by MACS from control or FAP no cilia mice 3 dpi with glycerol injection ( Figure 6A ). We identified 609 differentially expressed genes affected by loss of IFT88 (Table  S1 ). As activation of Hh signaling is able, like loss of cilia, to suppress adipogenesis, we compared cilia-dependent genes to previously identified Hh target genes (see STAR Methods). Three de-repressed genes identified by this analysis were Ptch1 and Gli1-both established general targets of Hh signaling-as well as Timp3 ( Figure S6A ). Timp3 encodes Tissue inhibitor of metalloproteinase 3, a secreted inhibitor of members of the matrix metalloproteinase (MMP) and ''a disintegrin and metalloproteinase'' (ADAM) families (Khokha et al., 2013) . qRT-PCR analysis of independent samples of purified FAPs from control and FAP no cilia mice confirmed that loss of FAP cilia increased expression of Timp3 ( Figure 6B ). As our data had indicated that both removal of cilia and removal of PTCH1 from FAPs blocks injury-induced adipogenesis, we examined whether, like loss of cilia, loss of PTCH1 increases Timp3 expression. qRT-PCR analysis of whole muscles of FAP no PTCH1 and control mice demonstrated that removing PTCH1 from FAPs also upregulates Timp3 expression ( Figure S6B ). As addition of TIMP3 to 3T3-L1 cells, a commonly used model of adipogenesis, had previously been shown to inhibit adipogenesis in vitro (Bernot et al., 2010) , we hypothesized that elevated Timp3 expression by FAPs may underlie the non-cell-autonomous suppression of adipogenesis caused by loss of cilia in vivo. Examination of ciliogenesis during 3T3-L1 adipogenesis revealed that nearly all 3T3-L1 cells possessed cilia prior to differentiation, but lost their cilia as they differentiated into adipocytes ( Figure S6C ), similar to previous reports (Marion et al., 2009; Zhu et al., 2009 ) and like FAPs in vivo ( Figure S2A ). Hh signaling had previously been shown to inhibit 3T3-L1 adipogenesis (Pospisilik et al., 2010; Suh et al., 2006) . We confirmed that activating Hh signaling with SAG inhibited 3T3-L1 differentiation into adipocytes: SAG induced expression of Gli1 and Ptch1 in a dose-dependent fashion, suppressed adipogenesis at low concentration (3 nM), and blocked adipogenesis at high concentration (100 nM) (Figure 6C and D) . Concordantly, SAG inhibited the induction of adipocyte genes such as Ppary, Adipoq, and Perilipin ( Figure S6E ).
To test whether the Hh pathway regulates Timp3 expression in 3T3-L1 cells, as it does in FAPs, we stimulated 3T3-L1 cells with SAG and assessed Timp3 expression by qRT-PCR. Activating Hh signaling potently induced Timp3 expression ( Figure S6F ).
If Hh signaling suppresses adipogenesis through induction of Timp3, we reasoned that inhibition of Timp3 expression should block the suppressive effects of SAG in 3T3-L1 cells. To test this hypothesis, we used siRNAs to suppress Timp3 expression ( Figure S6F ). Suppressing Timp3 expression blocked the ability of low SAG and reduced the ability of high SAG concentration to inhibit adipogenesis ( Figure 6C and D) . Similarly, knockdown of Timp3 blocked (in the case of low SAG) or reduced (in the case of high SAG) the repressive effect of Hh signaling on the expression of the adipocyte genes Pparg, Adipoq, and Perilipin ( Figure S6E ). Thus, in 3T3-L1 cells, Hh signaling acts through TIMP3, directly or indirectly, to repress adipogenesis. 
MMP14 Promotes Adipogenesis Downstream of or in Parallel to TIMP3
Adipogenesis involves the remodeling of the ECM by matrix metalloproteinases (MMPs) (Mariman and Wang, 2010) . If TIMP3 suppresses adipogenesis by inhibiting an MMP, inhibition of that MMP would also suppress adipogenesis. To identify MMPs that TIMP3 may inhibit in adipogenesis, we analyzed the RNA-seq data and identified two expressed MMPs that promote adipogenesis, MMP2 and MMP14 (also called MT1-MMP) (Bauters et al., 2015; Chun et al., 2006) , and two not recognized to affect adipogenesis, MMP16 and MMP23. To test for possible roles in promoting adipogenesis, we transfected 3T3-L1 cells with siRNA against MMP16 or MMP23 4 days prior to induction or treated cells with a pharmacologic inhibitor of MMP2 (MMP-2 Inhibitor II) at the day of induction. Inhibiting MMP2 or MMP16 function had no effect on adipogenesis, and inhibition of MMP23 induced cell death ( Figure S6G ), suggesting that these MMPs do not mediate the effects of TIMP3.
To assess MMP14 function, we used siRNA to inhibit 3T3-L1 expression of Mmp14 4 days before induction of adipogenesis. qRT-PCR confirmed inhibition of Mmp14 expression (Figure S6H) . Inhibiting Mmp14 inhibited adipogenesis ( Figures 6E and 6F) . As an independent test of the effect of MMP14 on adipogenesis, we tested whether inhibiting Mmp14 affected expression of the adipocyte genes Adipoq, Perilipin, and Pparg by qRT-PCR 3 days post induction of adipogenesis. Like removing cilia from FAPs, inhibiting Mmp14 repressed induction of these adipocyte genes ( Figure S6I ).
As TIMP3 inhibits MMP14 (Wei et al., 2005) and MMP14 promotes adipogenesis (Chun et al., 2006) , we inhibited both to assess whether MMP14 may act downstream of TIMP3. Using siRNA-mediated knockdown, we depleted Timp3 and Mmp14 in 3T3-L1 cells singly or in combination. Inhibiting both Timp3 and Mmp14 impaired adipogenesis, demonstrating that inhibiting Timp3 could not restore adipogenesis in the absence of MMP14 function ( Figures 6E and 6F ). The lack of rescue was confirmed by qRT-PCR for the adipogenic markers Adipoq, Perilipin, and Pparg ( Figure S6I ).
To further test whether MMP14 participates in adipogenesis, we treated 3T3-L1 cells with NSC405020, an MMP14-specific inhibitor. NSC405020 potently inhibited formation of adipocytes ( Figure S6J ). qRT-PCR analysis revealed that NSC405020 also repressed induction of the adipocyte genes Adipoq, Perilipin, and Pparg ( Figure S6I ). SiRNA-mediated depletion of Timp3 did not restore adipogenesis to NSC405020-treated 3T3-L1 cells ( Figures S6I and S6J) , consistent with an effect of MMP14 downstream of or in parallel to TIMP3 ( Figure 6G ). Thus, we propose that ciliary Hh signaling induces TIMP3 to restrict MMP14 activity, thereby inhibiting adipogenesis.
A Pharmacological Mimetic of TIMP3 Inhibits Intramuscular Adipogenesis In Vivo
As TIMP3 inhibits adipogenesis in vitro, we investigated whether TIMP3 may also inhibit adipogenesis in vivo. Cardiotoxin injection was marked by a transient decline in Timp3 expression, whereas glycerol injection, a more adipogenic injury, caused a sustained suppression of Timp3 expression, consistent with a role for TIMP3 in inhibiting adipogenesis ( Figure 7A ). To assess whether downregulation of TIMP3 activity promotes adipogenesis, we tested whether maintaining TIMP3-like activity can inhibit intramuscular adipogenesis. To mimic the activity of TIMP3, we made use of batimastat, a pharmacological inhibitor of metalloproteinases including MMP14 (Hotary et al., 2002; Macaulay et al., 1999) . We confirmed that batimastat inhibited 3T3-L1 cell adipogenesis (Chavey et al., 2003) (Figure 7B ).
Given its ability to inhibit adipogenesis in vitro, we assessed whether batimastat prevents injury-induced adipogenesis in vivo. WT mice were injected with batimastat at the day of injury by glycerol injection (day 0) and at 2 dpi. By 7 dpi, batimastat reduced adipocyte number within skeletal muscle by 70% (Figure 7C) . Thus, a small molecule mimetic of TIMP3 suppresses injury-induced muscle adipogenesis, revealing a pharmacological approach to blocking the mechanism by which cilia promote fat formation.
DISCUSSION
Replacement of muscle with fat is a sequela of both age and diverse chronic diseases. FAPs give rise to adipocytes following injury, and this conversion is regulated by Hh signaling through the primary cilium. Removing cilia from FAPs not only reduces intramuscular adipogenesis, but also enhances hallmarks of muscle healing. A Hh regulated secreted factor, TIMP3, inhibits MMP14 and restrains adipogenesis, pointing to a strategy for reducing fatty degeneration and improving the regeneration of skeletal muscle following injury.
In vertebrates, cilia are present on most cell types. To explore the post-developmental functions of cilia in skeletal muscle, we identified which muscle cell types are ciliated and found that, consistent with previous reports (Marion et al., 2009; Przybylski, 1971 ; Zhu et al., 2009), mature muscle fibers and adipocytes are not ciliated. Nonetheless, skeletal muscle contains many ciliated cells, most of which are FAPs.
Intriguingly, FAPs increase not only in numbers, but also in their ciliation during the early phases of regeneration. Thus, cilia are present at a time and place to control FAP fate. Genetic manipulation revealed that cilia promote the conversion of FAPs into adipocytes following injury. Similarly, in a model of DMD, cilia also promote the adipogenic conversion of FAPs, indicating that cilia influence adipogenesis both acutely following injury and in a model of chronic disease.
One of the most well-characterized functions of vertebrate cilia is the transduction of Hh signals. Similar to limb-bud development, removal of FAP cilia diminished formation of GLI3 repressor and depressed Hh target genes, indicating that ciliary Hh signaling can function similarly during development and tissue regeneration.
Like removal of cilia, activating Hh signaling in FAPs by conditionally deleting Ptch1 or administering SAG blocked injuryinduced adipogenesis. Our finding that Hh signaling restrains intramuscular adipogenesis parallels previously identified roles for Hh signaling in suppressing adipocyte differentiation in vitro and during development (Pospisilik et al., 2010; Suh et al., 2006) , underlining the importance of Hh signals in restricting adipogenesis in diverse settings.
Mesenchymal cell populations similar to FAPs exist in tissues beyond skeletal muscle, and in many of these tissues, ectopic fat formation is a consequence of chronic diseases (Montani et al., 2004; Pinnick et al., 2008) . The cells that give rise to fat in these tissues and the signals involved, however, are unknown. As a subset of mesenchymal cells in diverse tissues expresses the Hh target gene, Gli1 (Kramann et al., 2015) , we hypothesize that ciliary Hh signaling in these cells regulates fibrosis or adipogenesis through mechanisms similar to those employed by FAPs.
While overexpression of SHH can affect muscle regeneration (Piccioni et al., 2014a; Piccioni et al., 2014b) , it has not been clear whether injury induces an endogenous Hh signal. Schwann cells robustly expressed DHH upon cardiotoxin injury, but not glycerol injury, and cardiotoxin injury, but not glycerol injury, activated the Hh pathway. Because pharmacologically activating the Hh pathway, like cardiotoxin injury, suppressed adipogenesis, the induction of DHH may account for why cardiotoxin injury causes limited adipogenesis.
In other tissues, Hh signals from nerves control target cell behaviors (Brownell et al., 2011) . Intriguingly, denervating muscle causes intramuscular adipogenesis (Dulor et al., 1998) . It will be interesting to test whether diminished production of DHH by Schwann cells causes increased FAP conversion into adipocytes upon denervation.
Activation of the Hh pathway after injury diminishes with age or loss of Dystrophin in mice, correlating with increased intramuscular adipogenesis (Piccioni et al., 2014a; Piccioni et al., 2014b) . The inverse correlation between Hh pathway activation and adipogenesis raises the possibility that the deregulation of Hh signaling is a key determinant of age-associated FAP-mediated adipogenesis.
In FAPs, mosaic removal of cilia combined with fate mapping indicates that cilia act non-cell-autonomously to block adipogenesis, although we cannot exclude a partially cell autonomous effect. These results suggest that, in response to injury, FAPs expand and then communicate with each other to coordinate their fate. To determine how cilia non-cell-autonomously repress adipogenesis, we compared the transcriptomes of control FAPs and FAPs from which we had genetically removed cilia. We identified that ciliary Hh signaling in FAPs regulates expression of Timp3. Future experiments will determine whether Timp3 is a direct or indirect target of Hh signaling.
Timp3 encodes a secreted inhibitor of several MMPs and ADAM proteins, and overexpression of Timp3 reduces adipogenesis (Bernot et al., 2010; Khokha et al., 2013) . Suppressing Timp3 expression blocked the ability of Hh pathway activation to inhibit adipogenesis, providing complementary loss-of-function evidence for the role for TIMP3 in inhibiting adipogenesis. The finding that TIMP3 was required for the ability of Hh signaling to inhibit adipogenesis in 3T3-L1 cells indicates that TIMP3 operates downstream of or in parallel to Hh signaling.
How does TIMP3 inhibit adipogenesis? Although TIMP3 has MMP-independent functions (Nakajima et al., 2010; Qi et al., 2003) , the ability of batimastat to mimic the effect of TIMP3 on adipogenesis suggests that it acts through MMPs to suppress intramuscular fat formation. Both TIMP3 and batimastat inhibit MMP14 (Hotary et al., 2002; Wei et al., 2005) , and we found that inhibiting MMP14 function by either knockdown or pharmacological inhibitor blocked adipogenesis, consistent with previous data (Chun et al., 2006) . Our finding that MMP14 functions downstream of or in parallel to TIMP3 suggests that TIMP3 represses adipogenesis through inhibition of MMP14. We propose that MMP14 selective inhibitors may provide a means of suppressing adipogenesis and improving muscle regeneration without incurring prohibitive adverse effects (Devy et al., 2009) .
Following injury, MuSCs, supported by FAPs, produce new myofibers (Joe et al., 2010) . In myopathies, such as DMD, chronic destruction leads to loss of large myofibers. Excitingly, removal of FAP cilia increases myofiber size, both after acute injury and in Dmd mdx mice, suggesting that FAP cilia influence myofiber regeneration. One mechanism by which FAP cilia may influence myogenesis is via the suppression of adipogenesis itself. Alternatively, ciliary Hh signaling may independently affect myogenesis, perhaps through TIMP3, a previously described modulator of myogenesis (Liu et al., 2010) .
This work reveals that cilia have critical functions in coordinating adult skeletal muscle regeneration by interpreting Hh cues that direct FAP fate, that ciliary Hh signaling controls expression of the MMP inhibitor TIMP3, and that pharmacological modulation of MMP activity can inhibit intramuscular adipogenesis. Thus, our results uncover a mechanism by which cilia orchestrate intercellular communication during regeneration and point to new strategies to combat chronic muscle diseases.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Studies Ift88 tm1Bky , Gt(ROSA)26Sor tm1(EYFP)Cos and Ptch1 tm1Bjw alleles have been described previously (Ellis et al., 2003; Haycraft et al., 2007; Srinivas et al., 2001) . Pdgfra-CreERT mice (Tg(Pdgfra-cre/ERT)467Dbe) were kindly provided by Dwight Bergles (Kang et al., 2010) . Dmd mdx mice were purchased from the Jackson Laboratory (Stock No: 001801). Littermates lacking either the Cre, the null (in the case of Ift88) or the second floxed allele (in the case of Ptch1) served as controls, as these three controls displayed no differences in the number of intramuscular adipocytes in a range of experimental conditions ( Figures S2B, S3A and S4C ). Differences in intramuscular adipogenesis were observed in both male and female mice and, thus, both sexes were included in experiments (Figure S2B) . We have provided a list of all the genetically modified mice (sex and genotype) used per experiment (Table S2) . For experiments using exclusively WT mice, CD1 mice (Charles River) were used. Each mouse strain was initially outcrossed 1-2 times to CD1 mice before intercrossing and maintained by breeding to CD1 mice. Thus, all mice used in this study are on a mixed genetic background. Tamoxifen (Sigma T-5648) was dissolved in corn oil and administered by oral gavage (200-250 mg/kg) on two consecutive days to 10-12 week old adults 2 weeks before injury. All Dmd mdx mice received 2 doses of tamoxifen at 4-5 weeks of age and were aged until 1 year of age. In addition, all control mice regardless of sex or genotype underwent the same tamoxifen treatment. For 
Timp3
Thermofisher CAT#s75164
Timp3 Thermofisher CAT# s75165
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DNA primer sequences, see Table S3 Integrated DNA Technologies N/A muscle injuries, mice were anesthetized with isoflurane and 25-50ml of 10 mM cardiotoxin (Sigma, C9759) or 50% glycerol was injected into the tibialis anterior muscle. For batimastat and SAG treatment in vivo, 10-12 week old CD1 mice were injected intraperitoneally with 2 mg/kg batimastat (Tocris) or 175 mg/kg SAG (EMD Millipore) on the day of injury and two days post injury (Heine et al., 2011; Macaulay et al., 1999) . For proliferation studies, BrdU (50 mg/g body weight; Alfa Aesar) was administered either via intraperitoneal injection two hours before sacrificing or provided ad libitum via the drinking water (1 mg/ml) during the first 2 days post injury (Kopinke et al., 2012) . All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of California, San Francisco.
Cell Culture 3T3-L1 pre-adipocytes, a sub clone of NIH 3T3 cells, which were derived from a male Swiss albino mouse embryo, were purchased at passage 8 and cultured according to manufacturer's instructions (Zenbio). In brief, 3T3-L1 cells were cultured in preadipocyte medium comprised of high glucose Dulbecco's modified Eagle's medium (DMEM, GIBCO), 10% newborn calf serum (GIBCO) and GlutaMax (GIBCO) and media was changed every other day. Two days after cells reached confluency, adipocyte differentiation medium comprised of DMEM, 10% fetal bovine serum (GIBCO) and GlutaMax containing Insulin (0.862 mM; Sigma, I2643) and Troglitazone (5 mM; Sigma, T2573) was added. After three days in differentiation medium, 3T3-L1 cells were switched to maintenance medium (DMEM, 10% FBS, GlutaMax and 0.862 mM Insulin) until analysis. SAG (3 or 100nM, EMD Millipore, #566660), batimastat (10 mM; Tocris), MMP2-inhibitor II (10 mM, Calbiochem), NSC405020 (100 mM, Sigma) or 0.1% DMSO (ATCC) were added at time of induction with Insulin and Troglitazone. Gene knockdown was achieved using the Silencer select pre-designed siRNAs according to the manufacturer's instructions (Thermofisher). Briefly, 3T3-L1 cells were transfected four days prior to adding the induction cocktail with either scRNA control (4390843, Thermofisher), siRNAs against Timp3 (s75164 and s75165, Thermo Fisher Scientific), Mmp14 (s69920), Mmp16 (s69926) and Mmp23 (s77255) using Lipofectamine RNAiMax (Thermo Fisher Scientific).
METHOD DETAILS
Histology, Immunohistochemistry and Image Analysis Tissue fixation, processing and immunostaining were performed as described previously (Kopinke et al., 2011) . In brief, tibialis anterior muscle was fixed in 4% paraformaldehyde (PFA) for 2 hr at 4 C and cryopreserved with 30% sucrose overnight at 4C. One day later, muscles were embedded in OCT compound (Sakura Finetek) and snap frozen in liquid nitrogen-cooled isopentane. Muscles were cryosectioned at 10 mm at midbelly and 3-4 sections collected every 250-350 mm. The most representative of all sections was used for quantifying the number of adipocytes, while randomly selected images across all sections were recorded for all other quantifications. 3T3-L1s or MACS-purified FAPs, grown on glass coverslips, were fixed in 4% PFA for 10min. Sections and cells were incubated with primary antibodies in blocking solution (5% donkey serum in PBS with 0.3% Triton X-100) overnight at 4 C. To visualize BrdU, slides were treated with 800 U/ml DNase I for 20 min at room temperature in 40 mM Tris HCL (pH 7.4), 10 mM NaCl, 6 mM MgCl 2 and 10 mM CaCl 2 as previously described (Kopinke et al., 2012) . To visualize g-TUBULIN, tissue sections were incubated with 1% SDS in PBS for 5 min. Antigen retrieval using a Sodium Citrate Buffer (10mM Sodium Citrate, 0.05% Tween 20, pH 6.0) was required for PAX7 and MYH3. Primary antibodies used were: rabbit anti-ARL13B (1:1000, Proteintech #17711-1-AP), Rabbit anti-LAMININ (1:1000, Sigma #L9393), rabbit anti-NINEIN (1:10000, gift from James Sillibourne), goat anti-PDGFRa (1:250, R&D Systems #AF1062), chicken anti-GFP (1:1000, Avis lab #1020), rabbit anti-PERILIPIN (1:1000, Cell Signaling #9349), rabbit anti-FABP4 (1:500, Proteintech # 51035-1-AP), rabbit anti-DHH (1:1000, Genetex #GTX109762), rat anti-BrdU (1:1000, Abcam #AB6326), rabbit anti-cleaved CASPASE3 (1:250, Cell Signaling # 9664), mouse anti-TUB Ac (1:1000, Sigma #T6793), mouse anti-PAX7 (1:100, Developmental Studies Hybridoma Bank), mouse anti-MYH3 (1:100, Developmental Studies Hybridoma Bank # F1.652) and goat anti-g-TUBULIN (1:250, Santa Cruz #SC-7396). Alexa Fluor-conjugated secondary antibodies from Life Technologies (1:1000) in combination with directly conjugated probes Phalloidin-Alexa 647 (1:100, Molecular Probes # A22287) and wheat germ agglutinin (WGA)-Alexa 647 (Molecular Probes, #W32466) were added for 2 hr at room temperature. DAPI (Sigma) was used to visualize nuclei. Oil Red O staining was performed according to manufacturer's instructions (Lonza). Images from randomly chosen fields across several sections (each 250-350 mm apart) were acquired using a Leica SPE confocal microscope or a Zeiss Observer D1 microscope with an Axiocam MRc camera. The tiling function within the Leica LSA software was used to generate the crosssectional images of whole tibialis anterior muscles. All images were processed identically with Adobe Photoshop (CS5). ImageJ (v1.50b) was used to quantify the area occupied by Oil Red O positive adipocytes. In brief, images were converted to binary images using the Threshold function, followed by the Watershed function, and then the area occupied quantified using the Analyze Particle function (size at 0.0005-inf and circularity at 0.2-1). DMSO or scRNA controls were set to 100% with the experimental values compared to the controls. For cross sectional area measurements of fibers, LAMININ and Phalloidin stained muscle sections were thresholded and fiber areas quantified using the Analyze Particle function in ImageJ. For color coding of fibers based on size, the ROI Color Coder function was used (http://imagejdocu.tudor.lu/doku.php?id=macro:roi_color_coder). To quantify cilia, images with a Z resolution between 2-3 mm were randomly taken and primary cilia were identified by either the axonemal component acetylated tubulin (TUB AC ) or the ciliary membrane marker ARL13B, while basal bodies were identified by NINEIN or g-TUBULIN. To measure adipocyte size, we determined the diameter of adipocytes, as marked by FABP4, in 3-4 randomly taken 40x images from 3 control and 3 FAP no cilia mice.
Expression Studies
Whole muscle tissue was placed in in TRIzol (Thermofisher) and disrupted using the TissueLyser II (QIAGEN). Isolated FAPs were placed in buffer RLT and vortexed and RNA was isolated using the QIAGEN RNeasy kit. 100-250ng RNA was used to make cDNA (iScript cDNA synthesis kit, Bio-Rad). QRT-PCR was performed in technical triplicates on an ABI 7900HT real-time PCR machine (Applied Biosystems) using the EXPRESS SYBR GreenER 2X master mix (Invitrogen). Fold changes were calculated using the 2 ÀDDCT method (Schmittgen and Livak, 2008) and expression levels normalized to the average of the housekeeping genes Hprt, Dolk, Pde12 and Sra1. Primer sequences used in this study are listed in Table S3 . For RNAseq, a total of 5 control and 3 FAP no cilia samples were used. For each sample, tibialis anterior muscles from 2-4 mice were combined and FAPs were MACS-purified. To maximize yield, tibialis anterior muscles from both sides were injured and used. The TruSeq Stranded Total RNA Library Prep Kit (Ilumina) was used to generate the library, which was subsequently sequenced using an Illumina 2500 SE 50bp platform and aligned to the GRCm38.78 whole genome using STAR RNAseq aligner. Individual read counts were normalized to the geometric mean read count across all samples using DEseq. Using a cutoff of p < 0.05 and neglecting genes with less than 100 reads, 609 genes were identified. To enrich for likely Hh targets, these 609 genes were cross-referenced against five lists of previously identified Hh target genes (Table  S1 ) (Falkenstein and Vokes, 2014; Hsu et al., 2014; Ingram et al., 2002; Valin et al., 2009; Yu et al., 2009 ).
Cell Lysis and Immunoblot MACS-isolated FAPs from tibialis anterior muscle were lysed at 4 C using RIPA buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, protease and phosphatase inhibitors (Calbiochem and Roche, respectively). Cell lysates were cleared by centrifugation at 16,000 g for 10 min, and protein concentration was determined using a BCA assay (Thermo Fisher Scientific). The cell lysate was denatured at 100 C for 5 min in 6X SDS-PAGE loading buffer. 5-10 mg of cell lysates were resolved on 4%-15% TGX gradient gels (Bio-Rad Laboratories) and transferred to nitrocellulose membrane (Amersham). Membranes were blocked with 5% non-fat dried milk in TBS with 0.1% Tween, and then incubated with primary antibody overnight at 4 C. Primary antibodies used were mouse anti-GLI3 (1:1,000; gift of Suzie Scales, Genentech) and mouse anti-aTUB (1:5000; Sigma #T5168). After washing in TBS with 0.1% Tween, membranes were incubated in HRP-conjugated secondary antibody for 2hr at room temperature. Blots were developed with Western lightning enhanced chemiluminescence (PerkinElmer), and molecular weights were determined using full-range rainbow pre-stained protein standards (GE Healthcare).
Magnetic activated cell sorting
Magnetic activated cell sorting (MACS) of FAPs was performed as previously described (Heredia et al., 2013) . Briefly, tibialis anterior muscles were finely minced on ice with a scalpel and digested in Ham's F10 medium containing 0.016% Collagenase II (GIBCO) for 45 min in a shaking 37 C air incubator. The cell suspension was filtered through 100 and 40 mM filters and red blood cells were removed. For negative selection, suspended cells were incubated with biotinylated antibodies ($0.5 mg/mL) against anti-Integrin a7, anti-CD3 and anti-CD45 (Biolegend), followed by incubation with anti-Biotin microbeads. Samples were then run through LD columns (Miltenyi Biotec) followed by two washes with MACS buffer (0.5% BSA and 2.5 mM EDTA in dPBS). Unlabeled cells were collected and incubated with an anti-Sca1-PE antibody (Biolegend) followed by anti-PE microbeads (Miltenyi Biotec). Sca1-labeled cells were collected using LS columns (Miltenyi Biotec). After three washes with MACS buffer, cells were eluted and used for downstream applications.
QUANTIFICATION AND STATISTICAL ANALYSIS
3-6 biological replicates were used for all cell culture experiments and all experiments were repeated at least twice. All data were analyzed with GraphPad Prism (version 7) and represented as mean ± SEM. A paired two-tailed t test was used for two samples with a single variable. For more than two samples, one-way ANOVA followed by a Dunnett's multiple comparison test for one variable or a two-way ANOVA followed by Tukey's multiple comparison test for two variables was used. A p value less than 0.05 was considered statistically significant and is denoted as follows: *<0.05, **<0.01, ***<0.001 and ****<0.0001.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE86073. (legend continued on next page) (E) Immunofluorescence for lineage marker (EYFP, green) and cilia (ARL13B, red) after conditional removal of IFT88 in FAPs 7 dpi with glycerol injection. Arrowheads mark ciliated EYFP + FAPs. Scale bar is 20 mm. (legend continued on next page)
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